Hormone receptor (hr)-positive breast cancer Clinical Trials

Delta Trials indexes 2 clinical trials for Hormone receptor (hr)-positive breast cancer in its publicly accessible dataset. Of these, 1 enrolling participants at this time and 1 trial have reached completion. This research takes place spanning 18 research sites around the world. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.